Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 63,800
-100 (-0.16%)
Nov 2, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 412.04 billion as of October 30, 2026. It is the 17,727th most valuable company in the world and the 503rd biggest in South Korea. Its market cap has decreased by 51.16% in one year.
Market Cap
412.04B
Enterprise Value
493.59B
Revenue
251.08B
Global Rank
Country Rank
#503 South Korea
PE Ratio
28.51
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 412.04B, an increase of 474.46%. That is a compound annual growth rate of 10.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 412.04B | -51.41% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 624.39B |
| Proteina | 599.21B |
| Pharmicell | 564.04B |
| Onconic Therapeutics | 549.89B |
| Hyundai Bioscience | 518.22B |
| GI Innovation | 434.19B |
| GC Corp. | 415.33B |
| AbClon | 368.52B |